Pimecrolimus: all 45 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• 1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUXTerminatedNCT01692626Phase 2Results posted
• Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With EczemaCompletedNCT00946478Not applicableResults posted
• A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic DermatitisCompletedNCT00403559Phase 2Results posted
• Pimecrolimus Cream for Oral Lichen PlanusCompletedNCT00297037Phase 2Results posted
• Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton SyndromeCompletedNCT00208026Phase 1/2Results posted
• Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease ModificationTerminatedNCT00124709Phase 4Results posted
• 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic DermatitisCompletedNCT00120523Phase 3Results posted
• Combination Therapy for Atopic DermatitisCompletedNCT00119158Phase 4Results posted
• A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic OintmentTerminatedNCT06400511Phase 3
• Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of LifeCompletedNCT04900948Phase 4
• Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis AlbaStatus unknownNCT03834935Phase 2/3
• Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic DermatitisCompletedNCT03297502Phase 3
• Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic DermatitisCompletedNCT02896101Phase 3
• Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen PlanusCompletedNCT02443311Phase 4
• A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)CompletedNCT02376049Phase 1
• A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic DermatitisCompletedNCT02103725Phase 1
• A Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen PlanusStatus unknownNCT01524744Phase 2
• Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.CompletedNCT01177566Phase 4
• Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under OcclusionCompletedNCT00925730Phase 4
• Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ UltrasoundCompletedNCT00655512Phase 1
• Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic DermatitisCompletedNCT00610142Phase 2
• Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus ErythematosusCompletedNCT00608673Not applicable
• A Clinical Study in Children and Adolescents With Mild to Moderate Atopic DermatitisCompletedNCT00568412Phase 4
• Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-oldCompletedNCT00510003Phase 4
• Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical SettingCompletedNCT00509990Phase 4
• Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic DiseaseCompletedNCT00507832Phase 2
• A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic DermatitisCompletedNCT00484003Phase 4
• Clobetasol Versus Pimecrolimus for Vulvar Lichen SclerosusCompletedNCT00393263Phase 2
• Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic DermatitisCompletedNCT00367393Phase 4
• Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic DermatitisCompletedNCT00351052Phase 3
• Treatment of Oral Erosive Lichen Planus With Pimecrolimus CreamTerminatedNCT00321750Phase 2
• Pimecrolimus Cream 1% in Adult Patients With Perioral DermatitisCompletedNCT00232115Phase 3
• Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic DermatitisCompletedNCT00232011Phase 3
• Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic DermatitisCompletedNCT00231998Phase 3
• Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand DermatitisCompletedNCT00226707Phase 3
• Cutaneous Lupus Erythematosus and ElidelWithdrawnNCT00222183Not applicable
• Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic DermatitisCompletedNCT00150059Phase 4
• Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric SubjectsCompletedNCT00139581Phase 4
• Efficacy of Elidel Cream on Erosive Oral Lichen PlanusCompletedNCT00130572Phase 3
• Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic DermatitisCompletedNCT00130364Phase 4
• Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis SiccaCompletedNCT00128245Phase 2
• Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic DermatitisCompletedNCT00121381Phase 4
• Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) PatientsCompletedNCT00121316Phase 4
• Quality of Life Study in Adults With Facial EczemaCompletedNCT00120302Phase 4
• Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic DermatitisCompletedNCT00117377Phase 4

← Pimecrolimus overview